Inspired by the extraordinary selectivities of acylases, we envisioned the use of lipophilic oligopeptidic organocatalysts for the acylative kinetic resolution/desymmetrization of rac- and meso-cycloalkane-1,2-diols. Here we describe in a full account the discovery and development process from the theoretical concept to the final catalyst, including scope and limitations. Competition experiments with various alcohols and electrophiles show the full potential of the employed oligopeptides. Additionally, we utilized NMR and IR-spectroscopic methods as well as computations to shed light on the factors responsible for the selectivity. The catalyst system can be readily modified to a multicatalyst by adding other catalytically active amino acids to the peptide backbone, enabling the stereoselective one-pot synthesis of complex molecules from simple starting materials.
The total synthesis of the naturally occurring antibiotic GE81112A, a densely functionalized tetrapeptide, is reported. Comparison of spectral data with those of the natural product and the lack of biological activity of the synthesized compound led us to revise the published configuration of the 3-hydroxypipecolic acid moiety. This hypothesis was fully validated by the synthesis of the corresponding epimer.
Here we report the development of the first enantioselective Dakin-West reaction, yielding a-acetamido methylketones with up to 58 %eewith good yields.T wo of the obtained products were recrystallized once to achieve up to 84 %ee. The employed methylimidazole-containing oligopeptides catalyze both the acetylation of the azlactone intermediate and the terminal enantioselective decarboxylative protonation. We propose ad ispersion-controlled reaction path that determines the asymmetric reprotonation of the intermediate enolate after the decarboxylation.Even though the Dakin-West (DW) reaction dates back to 1928, [1] it is still one of the most effective synthetic procedures to prepare a-acylamido ketones from primary a-amino acids. [2] Generally,t he treatment of an amino acid with an acid anhydride and base,t ypically pyridine,a te levated temperature provides the desired product upon liberation of CO 2 (Scheme 1). Numerous modifications of the original reaction conditions were developed, [2] including catalytic variants, [3] broadening its scope and applicability.U nsurprisingly,the DW reaction found application in the preparation of a-acylamido ketones as valuable precursors for various biologically active compounds, [4] and even in Woodwards fundamental total synthesis of strychnine. [5] Remarkably,n o asymmetric variant has been developed to date,thus restricting the use of this important reaction in modern synthetic chemistry.
All
four possible stereoisomers of the natural product (−)-avicennone
C were synthesized using two different methods for ring closure. The
absolute stereochemistry was elucidated unambiguously by comparison
of the analytical data with those of the reported natural product
and by single X-ray crystal diffraction of synthetic intermediates.
The proposed structure needed to be revised with regard to the absolute
configuration of the stereogenic center bearing the secondary hydroxyl
group. The reported synthesis offers a flexible, selective, and efficient
access to all possible stereoisomers and may be of value for the stereoselective
synthesis of other epoxyquinone natural products.
TEMPO was immobilized on continuous-flow-optimized mesoporous silica particles and a TEMPO/DAIB mediated oxidation followed by Knoevenagel condensation was investigated.
Increasingly sensitive analytical
instruments and robust downstream
data processing tools have revolutionized natural product research
over the past decade. A molecular networking-guided survey led to
the identification of 33 new cyclic lipopeptides (CLPs) from the culture
broth of the proteobacterium Pseudomonas sp. FhG100052.
The compound family resembles members of the amphisin group of CLPs
that possess a 3-hydroxy fatty acid linked to the N-terminus of an
undecapeptide core. Culture optimization led to the isolation and
subsequent structure elucidation of one known and five new derivatives
by extensive MS/MS and NMR experiments in combination with Marfey’s
analysis. The data were in agreement with in silico analysis of the corresponding biosynthetic gene cluster. Most strikingly,
the length of the incorporated fatty acid defined the growth inhibitory
effects against Moraxella catarrhalis FH6810, as
observed by MIC values ranging from no inhibition (>128 μg/mL)
to 4 μg/mL.
New polyketides, termed veramycins, were isolated along with their known congeners NFAT-133 and TM-123. Total synthesis from a central building block was accomplished, the BGC identified and a biosynthetic pathway for this molecule class proposed.
Tuberculosis represents one of the ten most common courses of death worldwide and the emergence of multidrug-resistant M. tuberculosis makes the discovery of novel anti-tuberculosis active structures an urgent priority. Here, we show that (+)-floyocidin B representing the first example of a novel dihydroisoquinoline class of fungus-derived natural products, displays promising antitubercular hit properties. (+)-Floyocidin B was identified by activity-guided extract screening and its structure was unambiguously determined by total synthesis.The absolute configuration was deduced from a key synthesis intermediate by single crystal X-ray diffraction analysis. A hit series was generated by the isolation of further natural congeners and the synthesis of analogs of (+)-floyocidin B. Extensive biological and physicochemical profiling of this series revealed first structure-activity relationships and set the basis for further optimization and development of this novel antitubercular scaffold.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.